Protalix BioTherapeutics Inc (AMEX:PLX) concluded the trading at $2.39 on on Friday, February 21 with a fall of -1.65% from its closing price on previous day.
Considering stock’s 52-week price range provides that PLX hit a high price of $2.76 and saw its price falling to a low level of $0.82 during that period. Over a period of past 1-month, stock came adding 0.84% in its value.
In contrast, when we review PLX stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 100% Buy for it.
Digging deeper we become aware of the PEG ratio of the PLX stock which is currently positioned at 0. It further provides that stock’s current price level is -4.51% away from its 20-day simple moving average and is 8.73% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 48.43 while volatility remained at 4.33% over the past week which changes to 5.55% when measuring it over the past month. Beta is valued at 0.72, while measure of average true range or ATR is currently at 0.13.
The percentage of outstanding shares held by the insiders is 7.56% while it is 6.94% for the institutional holders. Addition of 27.13% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
